Among the 30+ AI-driven pipelines self-developed by Insilico, ISM5939 marks the 10th molecule to receive IND clearance. (IMAGE)

InSilico Medicine

Among the 30+ AI-driven pipelines self-developed by Insilico, ISM5939 marks the 10th molecule to receive IND clearance.

Caption

Insilico utilized proprietary generative AI engines affiliated to Pharma.AI to accelerate the early development of ISM5939, obtaining the lead compound within 3 months of project initiation. 

Credit

Insilico Medicine

Usage Restrictions

None

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.